Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia

Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia

Boris Decourt,1 Keith Noorda,2 Kevin Noorda,2 Jiong Shi,1 Marwan N Sabbagh3 1Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA; 2UNLV School of Medicine, Las Vegas, NV, USA; 3Alzheimer’s and Memory Disorders Division, Department of Neurology, Barrow Neurological Institute, St. Jo...

Full description

Bibliographic Details
Main Authors:	Decourt B, Noorda K, Shi J, Sabbagh MN
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-10-01
Series:	Journal of Experimental Pharmacology
Subjects:	alzheimer disease amyloid plaques clinical trials immunotherapy small-molecule drugs
Online Access:	https://www.dovepress.com/review-of-advanced-drug-trials-focusing-on-the-reduction-of-brain-beta-peer-reviewed-fulltext-article-JEP

Similar Items

Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
by: Wataru Araki, et al.
Published: (2022-01-01)

Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
by: Sharmin Reza Chowdhury, et al.
Published: (2019-08-01)

Beta-amyloid imaging in dementia
by: Kyung Ah Chun
Published: (2018-06-01)

Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD—VIVIAD
by: E. G. B. Vijverberg, et al.
Published: (2021-08-01)

Immunotherapies Targeting Amyloid and Tau Protein in Alzheimer’s Disease: Should We Move Away from Diseases and Focus on Biological Targets? A Systematic Review and Expert Opinion
by: Arthur Esquer, et al.
Published: (2023-10-01)

The effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus
by: Maryam Azhir, et al.
Published: (2023-01-01)

Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
by: David L. Brody, et al.
Published: (2017-08-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
by: Castillo-Carranza DL, et al.
Published: (2013-12-01)

Aging and Progression of Beta-Amyloid Pathology in Alzheimer’s Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression
by: Cristina Fernández-Mendívil, et al.
Published: (2020-07-01)

Human in vivo evidence of associations between herpes simplex virus and cerebral amyloid-beta load in normal aging
by: Jose L. Cantero, et al.
Published: (2024-04-01)

Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
by: Tadafumi Hashimoto, et al.
Published: (2020-12-01)

Aryloxypropanolamine targets amyloid aggregates and reverses Alzheimer-like phenotypes in Alzheimer mouse models
by: Hee Yang Lee, et al.
Published: (2022-11-01)

Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
by: George Tetz, et al.
Published: (2021-06-01)

An Overview of Several Inhibitors for Alzheimer’s Disease: Characterization and Failure
by: Subramanian Boopathi, et al.
Published: (2021-10-01)

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
by: Allal Boutajangout, et al.
Published: (2019-03-01)

Editorial on, Amyloid-beta clearance in Alzheimer’s disease.
by: Robert eMarr
Published: (2014-11-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments
by: I. V. Litvinenko, et al.
Published: (2019-11-01)

Transferrin-Conjugated Melittin-Loaded L-Arginine-Coated Iron Oxide Nanoparticles for Mitigating Beta-Amyloid Pathology of the 5XFAD Mouse Brain
by: Moonseok Choi, et al.
Published: (2023-10-01)

Involvement of Dab1 in APP processing and β-amyloid deposition in sporadic Creutzfeldt–Jakob patients
by: R. Gavín, et al.
Published: (2010-02-01)

Sticker-and-spacer model for amyloid beta condensation and fibrillation
by: Jack P. Connor, et al.
Published: (2022-10-01)

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
by: Chun-ling Dai, et al.
Published: (2018-01-01)

FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer’s Disease
by: Bisan Saleh, et al.
Published: (2022-08-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01)

The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
by: Eleanor Drummond, et al.
Published: (2022-04-01)

Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
by: M. Mahafuzur Rahman, et al.
Published: (2021-08-01)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
by: Anne-Cathrine S. Vogt, et al.
Published: (2023-02-01)

CRANAD-28: A Robust Fluorescent Compound for Visualization of Amyloid Beta Plaques
by: Kathleen Ran, et al.
Published: (2020-02-01)

Plasma Exchange Reduces Aβ Levels in Plasma and Decreases Amyloid Plaques in the Brain in a Mouse Model of Alzheimer’s Disease
by: Santiago Ramirez, et al.
Published: (2023-12-01)

Intranasal Delivery of Collagen-Loaded Neprilysin Clears Beta-Amyloid Plaques in a Transgenic Alzheimer Mouse Model
by: Christian Humpel
Published: (2021-04-01)

Organotypic vibrosections from whole brain adult Alzheimer mice (overexpressing amyloid-precursor-protein with the Swedish-Dutch-Iowa mutations) as a model to study clearance of beta-amyloid plaques
by: Christian eHumpel
Published: (2015-04-01)

Commentary: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
by: Isis Nem De Oliveira Souza, et al.
Published: (2016-01-01)

Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
by: Justyna Sosna, et al.
Published: (2018-03-01)

Istradefylline reduces memory deficits in aging mice with amyloid pathology
by: Anna G. Orr, et al.
Published: (2018-02-01)

Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala
by: Maria-Luisa Appleman, et al.
Published: (2024-01-01)

White Button Mushroom (<i>Agaricus bisporus)</i> Supplementation Ameliorates Spatial Memory Deficits and Plaque Formation in an Amyloid Precursor Protein Mouse Model of Alzheimer’s Disease
by: Thalia T. Dimopoulos, et al.
Published: (2022-10-01)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
by: Brittani R. Price, et al.
Published: (2020-08-01)

Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease
by: Xueting Wang, et al.
Published: (2023-10-01)

Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model
by: Heather C. Rice, et al.
Published: (2020-01-01)

Advance directives among cognitively impaired persons who had an amyloid PET scan and their care partners: a mixed-methods study
by: Emmanuelle Bélanger, et al.
Published: (2022-11-01)